Finance

Beta
Lists
MREO:NASDAQ
Mereo BioPharma Group plc - ADR
$0.32
-4.25%
(-0.014) 1D
$0.32
+0.88% (+0.0028)
After hours
Closed: Jun 30, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MREO...
Open
$0.33
High
$0.35
Low
$0.32
Mkt. cap
50.99M
Avg. vol.
5.30M
Volume
1.66M
52-wk high
$3.05
52-wk low
$0.20
EPS
-$0.22
Beta
0.28
Shares outstanding
159.62M
No. of employees
39
Open
$0.33
High
$0.35
Low
$0.32
Mkt. cap
50.99M
Avg. vol.
5.30M
Volume
1.66M
52-wk high
$3.05
52-wk low
$0.20
EPS
-$0.22
Beta
0.28
Shares outstanding
159.62M
No. of employees
39
News stories
From sources across the web
About Mereo BioPharma Group plc - ADR
CEODenise Scots-Knight
Employees39
Founded2015
Headquarters-
SectorBiotechnology
Websitemereobiopharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to MREO in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for MREO in the last 3 months.
Highest
Current $0.32
$3.00 (+844.29%)
Average
$3.00 (+844.29%)
Lowest
$3.00 (+844.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kate Dellorusso
LifeSci Capital
Hold
Maintained
-
-
05/12/2026
Gil Blum
Needham
Buy
Maintained
$3.00
+844.3%
05/12/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
$3.00
+844.3%
05/12/2026
Priyanka Grover
J.P. Morgan
Hold
Maintained
-
-
03/25/2026
Julian Harrison
BTIG
Buy
Maintained
$1.00
+214.8%
03/19/2026
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
500.00K
-
-
-
Cost of goods sold
132.00K
-
-
-
Cost of revenue
132.00K
-
-
-
Research and development expenses
4.63M
3.82M
3.72M
4.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.49M
6.04M
4.20M
4.02M
Operating expense
10.12M
9.87M
7.62M
8.67M
Total operating expenses
10.25M
9.87M
7.62M
8.67M
Operating income
-9.75M
-9.87M
-7.62M
-8.67M
Other non operating income
-101.00K
496.00K
-6.00K
17.00K
EBT including unusual items
-14.62M
-7.02M
-7.35M
-6.72M
EBT excluding unusual items
-14.62M
-7.02M
-7.35M
-6.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-300.00K
-
Net income
-14.62M
-7.02M
-7.35M
-6.72M
Net profit margin
-2,923.20%
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
589.00K
504.00K
421.00K
327.00K
Interest expense
-24.00K
-28.00K
-23.00K
-20.00K
Net interest expenses
565.00K
476.00K
398.00K
307.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.59M
-9.82M
-7.16M
-8.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer